BANK OF MONTREAL /CAN/ – Edwards Lifesciences Corporation Transaction History
BANK OF MONTREAL /CAN/ portfolio value:
$88.19M
portfolio value
BANK OF MONTREAL /CAN/ quarter portfolio value change:
-13.10%
quarter
Edwards Lifesciences Corporation 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Increase | +3.28% | 29.04K shares | -1.30M | $82.63 | 915.16K |
| Q2 2022 | share | Decrease | -9.06% | -88.28K shares | -24.61M | $95.09 | 886.11K |
| Q1 2022 | share | Decrease | -1.66% | -16.49K shares | -15.82M | $117.72 | 974.39K |
| Q4 2021 | share | Decrease | -20.23% | -251.24K shares | -11.59M | $130.68 | 990.89K |
| Q3 2021 | share | Increase | +13.68% | 149.51K shares | 28.16M | $113.21 | 1.24M |
| Q2 2021 | share | Increase | +35.70% | 287.46K shares | 45.59M | $103.57 | 1.09M |
| Q1 2021 | share | Decrease | -9.54% | -84.87K shares | -11.78M | $83.64 | 805.16K |
| Q4 2020 | share | Increase | +18.46% | 138.68K shares | 20.49M | $91.23 | 890.03K |
| Q4 2020 | call | Decrease | -100.00% | -53.7K shares | -4.22M | $91.23 | 0 |
| Q3 2020 | call | Increase | +168.50% | 33.7K shares | 2.85M | $79.82 | 53.7K |
| Q3 2020 | share | Decrease | -23.59% | -231.99K shares | -8.07M | $79.82 | 751.35K |
| Q2 2020 | share | Decrease | -24.06% | -311.55K shares | -12.66M | $69.11 | 983.34K |
| Q2 2020 | call | Increase | 0.00% | 20K shares | 1.36M | $69.11 | 20K |
| Q1 2020 | share | Decrease | -10.66% | -154.52K shares | -32.92M | $62.87 | 1.29M |
| Q4 2019 | call | Decrease | -100.00% | -49.2K shares | -3.60M | $77.76 | 0 |
| Q4 2019 | share | Increase | +40.40% | 417.09K shares | 37.04M | $77.76 | 1.44M |
| Q3 2019 | share | Increase | +27.10% | 220.11K shares | 25.65M | $73.3 | 1.03M |
| Q3 2019 | call | Increase | 0.00% | 49.2K shares | 3.60M | $73.3 | 49.2K |
| Q2 2019 | share | Increase | +2.34% | 18.55K shares | -600K | $61.58 | 812.19K |
| Q1 2019 | share | Increase | +6.27% | 46.81K shares | 12.48M | $63.78 | 793.64K |
| Q4 2018 | share | Decrease | -0.47% | -3.53K shares | -5.41M | $51.06 | 746.82K |
| Q3 2018 | share | Increase | +42.01% | 221.96K shares | 17.90M | $58.03 | 750.36K |
| Q2 2018 | share | Decrease | -39.72% | -348.15K shares | -15.12M | $48.52 | 528.40K |
| Q1 2018 | share | Increase | +23.86% | 168.83K shares | 14.17M | $46.51 | 876.55K |
| Q4 2017 | share | Increase | +44.20% | 216.92K shares | 8.70M | $37.57 | 707.72K |
| Q3 2017 | share | Increase | +2.39% | 11.46K shares | -1.00M | $36.44 | 490.8K |
| Q2 2017 | share | Decrease | -15.77% | -89.71K shares | 1.04M | $39.41 | 479.34K |
| Q1 2017 | share | Increase | +31.58% | 136.57K shares | 5.89M | $31.36 | 569.05K |
| Q4 2016 | share | Decrease | -43.41% | -331.79K shares | -18.76M | $31.23 | 432.48K |
| Q3 2016 | share | Increase | +0.02% | 150 shares | 5.31M | $40.19 | 764.27K |
| Q2 2016 | share | Decrease | -22.59% | -223.01K shares | -3.62M | $33.24 | 764.12K |
| Q1 2016 | share | Increase | +25.95% | 203.37K shares | 8.39M | $29.4 | 987.13K |